Cointime

Ikaria

company

About

Ikaria develop and deliver innovative therapeutics and interventions to meet the significant needs of critically.

  • 501 - 1000

Highlights

Total Funding Amount
$290M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$10M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
501 - 1000
Operating Status
Active

Ikaria develop and deliver innovative therapeutics and interventions to meet the significant needs of critically ill patients. It is our aim to be an indispensable partner to clinicians, providing help and critically caring just when patients need it the most.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$290M
Ikaria has raised a total of $290M in funding over 2 rounds. Their latest funding was raised on Mar 1, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 1, 2007 Series B $280M 1 — — Detail
Apr 27, 2005 Series A $10M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Ikaria is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners — Series B
Cointime
เนื้อหา
บริษัท